NAFDAC Urges Pharma Firms to Invest in Vaccine Production for Health Security

The Director General of NAFDAC, Prof. Mojisola Adeyeye, called on pharmaceutical companies in Nigeria to invest in vaccine production during a lecture at a NAPharm event in Lagos.

She emphasized the importance of local vaccine manufacturing to avoid being unprepared for future health crises like COVID-19. Adeyeye highlighted the need for regulatory improvements and mentioned NAFDAC's plans to separate vaccine regulation from other products.

The move aims to boost efficiency and align with global standards, ultimately leading to the local production of vaccines in Nigeria.